Elkfork Partners’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $27K | Hold |
3,584
| – | – | ﹤0.01% | 1015 |
|
|
2019
Q2 | $33K | Hold |
3,584
| – | – | ﹤0.01% | 1012 |
|
|
2019
Q1 | $19K | Sell |
3,584
-700
| -16% | -$3.71K | ﹤0.01% | 1018 |
|
|
2018
Q4 | $19K | Buy |
+4,284
| New | +$19K | ﹤0.01% | 980 |
|
|
2018
Q3 | – | Sell |
-47,656
| Closed | -$335K | – | 1026 |
|
|
2018
Q2 | $335K | Buy |
47,656
+2,380
| +5% | +$16.7K | 0.01% | 645 |
|
|
2018
Q1 | $644K | Hold |
45,276
| – | – | 0.02% | 458 |
|
|
2017
Q4 | $397K | Sell |
45,276
-5,012
| -10% | -$43.9K | 0.01% | 604 |
|
|
2017
Q3 | $588K | Buy |
50,288
+3,164
| +7% | +$37K | 0.02% | 449 |
|
|
2017
Q2 | $658K | Buy |
47,124
+18,704
| +66% | +$261K | 0.02% | 421 |
|
|
2017
Q1 | $390K | Hold |
28,420
| – | – | 0.01% | 496 |
|
|
2016
Q4 | $204K | Buy |
+28,420
| New | +$204K | 0.01% | 568 |
|